Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse Neuropeptide Y ELISA Kit (AC2938)
Cat.#: ASET-1527
Specifications
Description Mouse Neuropeptide Y ELISA Kit allows for the in vitro quantitative determination of mouse Neuropeptide Y concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 18.75 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 31.25-2000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2113 Rat NT-4 ELISA Kit (AC3524) Quantitative inquiry ASET-1661 Mouse c-Kit ELISA Kit (AC3072) Quantitative inquiry ASET-1484 Mouse alpha Synuclein ELISA Kit (AC2895) Quantitative inquiry ASET-1445 Mouse ABCA7 ELISA Kit (AC2856) Quantitative inquiry ASET-1341 Chicken Acetylcholinesterase ELISA Kit (AC2752) Quantitative inquiry ASET-1769 Rat GRK2 ELISA Kit (AC3180) Quantitative inquiry ASET-1051 Human LAMP1 ELISA Kit (AC2462) Quantitative inquiry ASET-1227 Mouse Sorcs1 ELISA Kit (AC2638) Quantitative inquiry ASET-2300 Human UNC5B ELISA Kit (AC3711) Quantitative inquiry ASET-1139 Mouse Atg10 ELISA Kit (AC2550) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket